サンバイオ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4592/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/01/15 | 日証協 | 337,260株 | -1.92% | 84,730株 | +2.92% | 524,488株 | +0.1% | 26,400株 | +67.09% |
2016/01/08 | 日証協 | 343,860株 | +10.84% | 82,330株 | -68.45% | 523,988株 | +5.97% | 15,800株 | -94.09% |
2015/12/30 | 日証協 | 310,230株 | +58.97% | 260,925株 | +1966.73% | 494,463株 | +30.4% | 267,150株 | +261.5% |
2015/12/25 | 日証協 | 195,155株 | -38.15% | 12,625株 | -89.4% | 379,188株 | -2.74% | 73,900株 | -21.04% |
2015/12/18 | 日証協 | 315,530株 | -14.61% | 119,100株 | +230.56% | 389,888株 | +4.04% | 93,595株 | +100.85% |
2015/12/11 | 日証協 | 369,530株 | +14.61% | 36,030株 | -76.7% | 374,763株 | +24.22% | 46,600株 | -32.97% |
2015/12/04 | 日証協 | 322,425株 | +1.7% | 154,625株 | +331.91% | 301,688株 | -2.24% | 69,525株 | +350.99% |
2015/11/27 | 日証協 | 317,025株 | -0.63% | 35,800株 | -63.02% | 308,587株 | +1.08% | 15,416株 | -8.32% |
2015/11/20 | 日証協 | 319,025株 | +62% | 96,800株 | +813.21% | 305,297株 | +32.11% | 16,815株 | +14.2% |
2015/11/13 | 日証協 | 196,925株 | -29.31% | 10,600株 | -91.69% | 231,092株 | -20.56% | 14,724株 | -54.38% |
2015/11/06 | 日証協 | 278,575株 | -11% | 127,575株 | +174.35% | 290,893株 | -5.56% | 32,275株 | +70.77% |
2015/10/30 | 日証協 | 313,000株 | +16.57% | 46,500株 | -53.31% | 308,018株 | +9.53% | 18,900株 | -51.41% |
2015/10/23 | 日証協 | 268,500株 | -1.97% | 99,600株 | +30.54% | 281,218株 | -14.74% | 38,900株 | +480.6% |
2015/10/16 | 日証協 | 273,900株 | -12.52% | 76,300株 | +34.57% | 329,818株 | -6.99% | 6,700株 | -76.57% |
2015/10/09 | 日証協 | 313,100株 | +14.27% | 56,700株 | +1790% | 354,618株 | +25.08% | 28,600株 | -58.78% |
2015/10/02 | 日証協 | 274,000株 | -3.45% | 3,000株 | 0% | 283,518株 | -0.64% | 69,389株 | +1209.23% |
2015/09/25 | 日証協 | 283,805株 | -2.54% | 0株 | -100% | 285,334株 | +1.24% | 5,300株 | -89.48% |
2015/09/18 | 日証協 | 291,205株 | -18.86% | 74,600株 | -40.18% | 281,834株 | -18.34% | 50,400株 | -42.73% |
2015/09/11 | 日証協 | 358,905株 | -1.67% | 124,700株 | -32.08% | 345,134株 | -10.66% | 88,000株 | +33.64% |
※株式分割は考慮していませんのでご注意ください。
Page Top